Tirzepatide's dual GLP-1/GIP action outperformed GLP-1-only drugs like semaglutide, suggesting GIP adds real value beyond just GLP-1
Noom members on GLP-1s actually log more meals, weigh in more often, and log more exercise by their second month than those on Noom without a GLP-1
Cochrane Metabolic and Endocrine Disorders Group, ed
Back Vinfuture Prize Laureates, 'Professor Joel Francis Habener'
Research areas triple agonist signalling research, body composition studies, and glucose and lipid metabolism models
Constipation, reflux, and when to hold your dose For constipation, which hits a meaningful percentage of women on retatrutide due to slowed gastric motility, fiber supplementation is first-line management before any pharmaceutical interventions